2006
DOI: 10.1136/bmj.333.7558.83
|View full text |Cite
|
Sign up to set email alerts
|

Testing pitfalls and summary of guidance in lipid management

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2006
2006
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 12 publications
0
6
0
Order By: Relevance
“…An audit was done to assess the proportion of abnormal results that were followed up correctly compared with the audit standard of a 100% correct follow-up rate. Correct follow-up was defined by guidelines that were taken from national guidelines, literature reviews or studies [6][7][8][9][10][11][12][13] and advice from experts in the relevant fields. The guidelines (see an online supplement to this paper) aim to ensure that patients get the correct follow-up by ensuring that appropriate blood tests and other investigations are done at the appropriate time and then referred, as required, to the correct service.…”
Section: Description Of Original Servicementioning
confidence: 99%
See 1 more Smart Citation
“…An audit was done to assess the proportion of abnormal results that were followed up correctly compared with the audit standard of a 100% correct follow-up rate. Correct follow-up was defined by guidelines that were taken from national guidelines, literature reviews or studies [6][7][8][9][10][11][12][13] and advice from experts in the relevant fields. The guidelines (see an online supplement to this paper) aim to ensure that patients get the correct follow-up by ensuring that appropriate blood tests and other investigations are done at the appropriate time and then referred, as required, to the correct service.…”
Section: Description Of Original Servicementioning
confidence: 99%
“…DS4) was devised in discussion with a biochemist specialising in lipid management at the University Hospital of North Durham and with reference to the literature. 10,13 Whether a patient gets lipid-lowering treatment depends on the 10-year cardiovascular risk calculations, and so information obtained on this through monitoring is forwarded to the GP with the referral.…”
Section: Guidelines For Follow-up Of Patients On Clozapinementioning
confidence: 99%
“…This guidance should be read in conjunction with reviews 1 and 3 of this series, which consider monitoring other aspects of cholesterol and triglyceride measurement, 20 21 which are accompanied by a further discussion in a case study on lipids in a series of articles in the BMJ. 22 When and how often should HDL-C be measured together with total cholesterol and LDL-C? We recommend that when assessing cardiovascular risk:…”
Section: High-density Lipoprotein Measurement and Treatmentmentioning
confidence: 99%
“…Individuals with neurodevelopmental disorders, including autism spectrum disorders (ASD), often display a wide range of symptom presentations, cognitive abilities, and behavioral profiles (Seelaar, Rohrer, Pijnenburg, Fox, & van Swieten, 2011; Smellie, 2006; Zetusky, Jankovic, & Pirozzolo, 1985). Characterizing these heterogeneous patterns represents a crucial question: Identification of distinct subgroups may provide important theoretical information regarding how underlying clinical impairments relate to prominent manifestations of disorders and may also provide critical information to facilitate targeted remediation of clinical symptoms within a specific subgroup.…”
mentioning
confidence: 99%